E-ISSN 2231-3206 | ISSN 2320-4672

2018, Vol:7,Issue:6

Research Articles
  • Indi J Medic Science and P Health.2018; Volume:7(6):427-433 doi : 10.5455/ijmsph.2018.0206709032018
  • Placental protein 13, galectin 14 and pentraxin 3 for prediction of preeclampsia in Egyptian patients
  • Fahmy T Ali, Ahmed M Ibrahim, Nahla S Hassan, Reham M Soliman

Abstract

Background: Pre-eclampsia (PE) is considered one of the most dangerous pregnancy complications, and the leading cause,of maternal and perinatal mortality and morbidity.
Objective: The aim of the current study was to evaluate two galectins,(GAL) and some biochemical parameters in the diagnosis of PE.
Materials and Methods: The study included a total of,96 women, including 66 pregnant women with PE, and 30 normotensive pregnant females. The biomarkers studied, at the,3 trimesters, included GAL13 and 14, pentraxin 3 (PTX3), C-reactive protein (CRP), liver function tests, and lipid profile.,
Results: Results indicated that a significant difference in GAL13 and 14 and PTX3 in preeclamptic women compared to,normotensive pregnant ones. The level of CRP showed non-significant change in all patient’s groups. Liver function tests,,total cholesterol, low-density lipoprotein cholesterol, and triacylglycerols revealed a high significant increase in all patient’s,groups. Levels of high-density lipoprotein cholesterol were highly significant decreased in 2nd and 3rd-trimester patients.,Conclusion: The specificity and sensitivity of GAL14 provided the highest diagnostic information of these biomarkers and,are in close to GAL13 and PTX3; while, CRP yielded a significantly worse accuracy for diagnosing PE.